Monitor the activity of three enzymes in one microplate well
Screening for these inhibitors will hopefully reveal new antimalarial agents.
Malaria is a mosquito-borne disease which results when a host organism is infected with the protozoan parasite Plasmodium vivax or other members of the genus Plasmodium. While the disease is restricted to the tropics it still accounts for nearly one million deaths per year. Therefore the search for new treatments is an area of intense research.
During an infection metalloaminopeptidases digest host hemoglobin and are essential for parasite survival. So, finding inhibitors of these enzymes could result in novel therapeutic options.
As with all screening strategies it is important to decrease the amount of compound used. To this end the current application note details a technique that can monitor activity of three metalloaminopeptidases at the same time.
Using the multifunctional capabilities of the FLUOstar Omega from BMG LABTECH the breakdown of substrates was monitored using fluorescence and absorbance modes. Thus kinetic assessment of enzyme activity could be monitored and inhibitors could be screened.